Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Breast cancer part of Jimmy Mengel's pump he did.
A member shared a email from Josh Blacher this morning. It sounds like Ado hasn't went anywhere. Also in the Email he pretty much called Jimmy Mengel's pump BS!
A number of investors have emailed and called. Nobody is getting any response. Everyone is still long but we just want an answer about Ado Mohammad.
Les, I get a suspicion Ado is gone. Another investor on the FB group did some digging and saw Muhammad was the only one not to get options in March. We are still waiting answer from Josh.
They have in their goals and milestones to announce partnership and biosynthesis inm the 3Q! If we dont hear a word by end of this Q, I might start thinking of an exit strategy. At some point they have to start generating revenue to satisfy TSX requirements and Eight Capital isn't going to like their money staying stagnant. They'll want return on investment. Inmed will have to put up or shut up at some point.
I will but if he did leave, what would disappoint me most is Inmed didn't release that information. Plus Ado is a rock star, a ton of people invested in this company mainly because of his work with GW and then coming over to Inmed.
They dont update their website as often as they should. Plus I feel leaving Ado Muhammad out is like the Lakers leaving out Lebron when announcing their starting 5. I emailed Josh yesterday but still waiting response. Their are a few other investors really curious about it as well.
Who are you referring to?
Les, why do you think Inmed wouldn't list Ado Mohammad's name today under the Executive team portion of the presentation. I'm a little concerned about his status with the company. Do you happen to know if he still is CMO of inmed?
He's talking short term, trading the stock.
Thanks Les, maybe by the time I retire in 20 years this will be ready! Lol
That is computer generated. In 5 years make that at least $22.44.
I have no doubt in my mind, we sit on this for a few years and we are going to be rewarded handsomely!
That was a transcript of his live webcast on Wednesday. Yes he's selling a subscription but his #1 medical Cannabis company is Inmed! Take it with a grain of salt. He is right about a number of things! Inmed has a lot of ways to make money and their leadership team is 2nd to none.
If anyone doesn't think this is Inmed, they must know nothing about this company! Just the CEO profile alone! That is Eric Adam's profile to a T!
JIMMY:
I have a couple interviews posted with the CEO. He’s a seasoned biopharmaceutical executive with 25 years of experience. He was CEO before of a gene therapy company, and also worked at Abbott Laboratories, a company with a $100 billion market cap.
He wasn’t the only one I was impressed with. The company was founded by a doctor and a pair of successful entrepreneurs who’ve started multiple companies in multiple industries.
NICK:
What makes them such a compelling buy right now?
JIMMY:
Well, they have a lot of irons in the fire. First, they are treating a rare skin disease that affects 50,000 -100,000 people, mostly children. Those who unfortunately get it lose up to 90% of their skin. And there’s no treatment.
This company is producing a cream that heals the skin. Estimates to fix just the symptoms, not even cure it, could be millions of dollars alone.
NICK:
What else are they working on?
JIMMY:
They’re also tackling glaucoma. That’s a much more well-known disease affecting over 200,000 people each year.
It’s the leading cause of irreversible eye damage nationwide. The market for this disease is around $2.6 billion in 2016. And that should almost double in the next 8 years.
The company I’ll show you today just filed a Patent Cooperation Treaty application for a CBD topical therapy for glaucoma. It includes protection of their unique technology in over 150 countries, including the US.
Meaning, once they dial it up correctly, this company could take off overnight.
NICK:
They have eye drops for glaucoma already though.
JIMMY:
Yeah, what folks don’t know is that 90-95% of the stuff washes away instantly when you blink. You’re left with 5% fighting for you. This company created a gel that coats the eye and penetrates in.
NICK:
That’s pretty interesting. Are they working on anything else?
JIMMY:
They are also working in the $635 billion pain space helping with what is known as the ‘suicide pain.’
They have 3 shots on goal into potential billion-dollar markets. I’m confident they could nail 1 or more.
And that’s not all.
They are also in the beginning stages for breast cancer cures using cannabis. It’s still early, but billions are also spent on breast cancer each year.
NICK:
How are you Les? Haven't heard from you in a bit. You we're the first one I talked with after I bought Inmed over a year ago. First one to tell me to have patience with this one. Boy, you weren't kidding! Lol. Are you still long and strong with Inmed? Just as much confidence?
I personally think they just reorganized their priorities. Upscaling Biosynthesis has become their #1 priority.
Nick, you need to do some DD! EA did not sell all of his shares in January and if you haven't noticed, he just loaded up with 500k shares and warrants! This is definitely not a scam! I dont blame them if they sell some shares to get a paycheck while there isn't any revenue yet! This A team didnt come together to be a scam! Sorry to disappoint you.
No inside info. He said nothing. Just to buy it I can.
Not much, just to buy as many shares as I can.
No not emotional, that wasn't the only reason I sold. I honestly don't see this getting close to silver again! Not with over 5Billion+ shares!
I owned this stock for a while. I was always thinking this thing could take off even with billions of shares. The CEO came to my bar a few times in Vegas. He told me he would send me a Med Tainer. Gave him my address and thought he's a man of his word. Months later, no Med Tainer! I sold every single share. I know it might seem like a little thing to everyone here but it wasn't to me. If I say I'm going to do something, I do. GLTA!
I have done my DD, they've pushed CT back until 2nd H 2019 so we still have to wait awhile to get much news for EB. I think our next big News release will come from Biosynthesis and Partnerships. Hopefully by end of the year! I'm hoping Biosynthesis is commercially ready by 1st H next year. JMO
Looks like this will slowly bleed until we get news! Hopefully soon.
I think it means they're moving forward with upscaling biosynthesis and preparing for CT next year! I think this is a good sign!
I'm in the U.S so I can't buy any Warrants.
It makes you wonder! Why would Eught Capital invest 15M in them! Do we really know Eli Lilly isn't interested? Could be talks behind closed doors. I personally think if there isn't major news by years end a ton of longs will be jumping ship. It's also hard to believe Ado Mohammed and Hossein came to Inmed to be part of a scam run by Bogart. Next few months will tell us a lot.
He keeps reposting that article to fight the trolls on the Yahoo board. I've asked him a few time why he keeps putting it up when all it's for is to sell subscriptions. That's his answer. I'm with you though, my patience is really being tested here. They pushed back Inm750 CT back a year and we are hearing nothing regarding Biosynthesis upscaling. We really need to get some news about partnerships bu end of this qtr. If we dont, I will be really disappointed.
Yes, being patient, I think we could start hearing some news in September. Going into 4th qtr. By years end should tell us a lot.
Hopefully one day we will get some news!
What was your take on that interview?
I personally think synthetic isn't nearly as good as the Biosynthesis process plus I'm hoping Inmed will make a ton of cash off the small hard to get Cannabinoids. That being said, I really need to hear some significant news by years end!
They had about 10M before the financing deal then got another 14M with the deal. Roughly around 24M. Eric during his last interview said they have enough cash for at least 2 years.
I honestly just think Inmed is prioritizing Biosynthesis above all else. Fastest way to revenue.
Thanks for the video, I shared that on another Inmed board.
I agree! Breast cancer treatment is years away! The only thing from the video you can take away is the potential of Inmeds Biosynthesis technology. Maybe Inm750 being fast tracked. He didn't mention that but that's the only thing I can think of when he talks about the deal with the FDA. FYI, there will be no announcement in the next 90 days about a deal with the FDA!Lol! He was right on about the greatness of our leadership group!
Were holding up alright!
So it’s no stretch to say the tiny $184 million firm — that’s just invented a brand-new type of pot specifically to treat breast cancer — is set to soar as high as 6,263%.
And that could happen within the next 90 days — here’s why...
Here is a part of his article, not misleading at all?